Argen X【ARGX】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

582.60

買値

575.00

売値

583.00

出来高

74,861

569.60 日の範囲 583.80

271.00 52 週間の範囲 583.80

時価総額

34.486B

前日終値

564.80

始値

571.00

時刻

420

582.6

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

59,587

発行済株式数

59,194,000

配当利回り

PER

-116.88

1 株当たり利益 (EPS)

-4.98

歳入

1.27B

純利益

-295.05M

セクター

Coml Physical, Biologcl Resh

業界

Coml Physical, Biologcl Resh

ウェブサイト

www.argenx.com

本社

Amsterdam, North Holland, Nld

設立

Argen X SE is listed in the Coml Physical, Biologcl Resh sector of the ユーロネクスト with ticker ARGX. The last closing price for Argen X was 564.80 €. Over the last year, Argen X shares have traded in a share price range of 271.00 € to 583.80 €.

Argen X currently has 59,194,000 shares in issue. The market capitalisation of Argen X is 33.43 € billion. Argen X has a price to earnings ratio (PE ratio) of -116.88.

argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies

Phase 2 data establish proof-of-concept of efgartigimod SC in myositis Enrollment to continue in Phase 3 across all three subtypes (IMNM, ASyS, DM) under evaluation in ALKIVIAPotential for...

argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China

First and only NMPA-approved treatment for patients with CIDP in China Second VYVGART Hytrulo indication approved in China November 11, 2024 – 7:30am ET Amsterdam, the Netherlands— argenx...

argenx to Participate at Upcoming Investor Conferences

November 5, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

argenx Reports Third Quarter 2024 Financial Results and Provides Business Update

$573 million in third quarter global net product sales CIDP global expansion on track, with decisions on approval under review in Japan, Europe, China, and Canada Management to host conference...

argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024

October 24, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

argenx Highlights Data Showing Patient Impact Across Multiple Immunology Programs at 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting and Myasthenia Gravis Foundation of America Scientific Sessions

Long-term and real-world data of VYVGART® (efgartigimod alfa-fcab) and VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) demonstrate speed of onset, depth of response, and durability...

argenx Announces Publication in The Lancet Neurology of Pivotal ADHERE Study Data in Chronic Inflammatory Demyelinating Polyneuropathy

ADHERE was largest and most innovative clinical trial of CIDP patients to date VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) demonstrated reduction in disease progression, reduced...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	25	4.48350071736	557.6	583.8	527.8	70589	546.91129326	DE
4	68.8	13.3904242896	513.8	583.8	507.4	66402	545.79575091	DE
12	112.2	23.8520408163	470.4	583.8	456.3	59587	508.55025273	DE
26	253.1	76.813353566	329.5	583.8	328.1	61883	454.98215761	DE
52	132.6	29.4666666667	450	583.8	271	64558	408.70258879	DE
156	328.6	129.37007874	254	583.8	224.1	65671	367.83495368	DE
260	452.8	348.844375963	129.8	583.8	93.05	75065	291.13213868	DE

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
MLAAHAmatheon Agri Holding NV	0.02 € (100.00%)	5k
GNROGeNeuro SA	0.0768 € (25.49%)	200
BIDSGascogne DS	0.005 € (25.00%)	150.51k
ALSAFSAFE	0.11 € (23.73%)	39.98k
ALKKOKKO International SA	0.112 € (21.21%)	4.13M
ALIMOGroupimo	0.189 € (-40.94%)	392
MLUMGUmalis Group	1.30 € (-31.22%)	1.71k
MLNMAMiguet Et Associes	0.075 € (-24.62%)	1.72k
MLSEQSequa Petroleum NV	0.008 € (-20.00%)	23k
VACBSPierre & Vacances	0.05 € (-15.25%)	35.99k
BCPBanco Comercial Portugues SA	0.4446 € (-0.49%)	69.24M
ALNEVNeovacs	0.0002 € (0.00%)	41.4M
ALCYBCybergun	0.0001 € (0.00%)	30.32M
INGAING Groep NV	14.652 € (-1.16%)	14.06M
ACACredit Agricole SA	13.05 € (-1.66%)	8.06M